Yeah, NMUS has been on my radar for a long time, have been involved since early 2017, well before any of the Emerald stuff.
Initial blocks were .35 - .40, but grabbed a fair amount down at .12 and brought my average down to < .20
Was kind of irresistible to scoop up a biopharm with such a low market cap. I did quite well with CBIS a year or two ago, but felt that that company was kind of junk compared to this one, so waited patiently for this one to get some of the attention that it deserved.
Would love to jump back in if I can get a decent entry point. Don't want to repeat the time I spent 2 days trying to buy CNBX at .06 - .07 and it jumped to over $5.00... lol
News 
Market Data 
Discover 
